Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

29.67 +0.67 (+2.31%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

61 62 Next >

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

August 21, 2025

From Pomerantz LLP

Via GlobeNewswire

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 21, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 21, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets ↗

August 21, 2025

The race inside the weight loss industry is ramping up, leaving investors with three names to choose from in how they want to play this theme.

Via MarketBeat

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS

August 20, 2025

From SkyMedia, LLC

Via GlobeNewswire

Deadline Approaching for Investors of Hims & Hers Health, Inc. (HIMS) - Contact Kaplan Fox Before August 25, 2025

August 20, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Approaching for Investors of Hims & Hers Health, Inc. (HIMS) - Contact Kaplan Fox Before August 25, 2025

August 20, 2025

Via TheNewswire.com

Topics Lawsuit

HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

August 20, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 20, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 20, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS

August 19, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Why Hims & Hers Health (HIMS) Stock Is Falling Today

August 19, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.4% in the afternoon session after investors took some profits off the table as markets awaited signals on future monetary policy from...

Via StockStory

Topics ETFs Economy Lawsuit

What's Going On With Hims & Hers Shares Today? ↗

August 19, 2025

Hims & Hers Health shares are trading lower Tuesday after GoodRx announces a collaboration with Novo Nordisk.

Via Benzinga

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 19, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 19, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4 ↗

August 18, 2025

A chip stock that recently partnered with NVIDIA. Now, a key company insider is buying over $160 million in shares, a bullish signal to investors.

Via MarketBeat

Topics Artificial Intelligence

Autonomous Vehicles Hit an Inflection Point; GPT-5 Is Here ↗

August 18, 2025

Motley Fool Money checks in on some stock market news.

Via The Motley Fool

Topics Economy

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 18, 2025

Via Benzinga

Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets ↗

August 18, 2025

GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies across the U.S.

Via Benzinga

Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 18, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS

August 18, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (NYSE: HIMS)

August 18, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

CoreWeave, Applied Materials And Hims & Hers Are Among Top 10 Large Cap Losers Last Week (August 11-August 15): Are The Others In Your Portfolio? ↗

August 17, 2025

Ten large-cap stocks, including CRWV, COHR & AMZN, were the worst performers last week. Weak results, downgrades, and FTC probe may be the reasons.

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

August 17, 2025

From Pomerantz LLP

Via GlobeNewswire

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

August 16, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of Hims That A Lawsuit Has Been Filed and Urges Investors to Contact The Firm Before the August 25th Deadline

August 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Investors Who Lost Money on Hims & Hers Health, Inc. (HIMS) Should Contact Levi & Korsinsky About Pending Class Action - HIMS

August 15, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Investors Who Lost Money on Hims & Hers Health, Inc. (HIMS) Should Contact Levi & Korsinsky About Pending Class Action - HIMS

August 15, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Hims & Hers Stock Slips As FTC Probe Into Subscription Practices Resurfaces ↗

August 15, 2025

Via Benzinga

1 Stock Under $50 with Solid Fundamentals and 2 We Ignore

August 15, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

61 62 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.